Pristiq Withdrawal and Tapering Help
Pristiq has higher rates of withdrawal symptoms (discontinuation syndrome) than other SNRI or SSRI antidepressants. Contact the Prescription Drug Experts for help! Our NonProfit has been helping people withdraw safely for over 14 Years.
In relation to its parent substance, Venlafaxine, Pristiq seemed to be less effective with no advantages in terms of safety and tolerability." Wyeth subsequently withdrew its application for approval.
Pristiq has higher rates of withdrawal symptoms (discontinuation syndrome) than other SNRI or SSRI antidepressants. For some patients the symptoms can be severe and are considered intolerable. A gradual taper is recommended
to minimize symptoms. Pristiq is the active metabolite of Venlafaxine and can have significant withdrawal symptoms.
if you need help tapering Pristiq or have questions.
Click here for more information on Pristiq.
Real Results for Pristiq Dependency
The Point of Return Program is an in-home tapering program that allows you to gradually lessen the amount of Pristiq while also implementing the use of all-natural, calming nutraceuticals to help ease symptoms. We eliminate
Interaction items to help make Pristiq withdrawal more comfortable. Our physician recommended schedules allow your doctor to taper you off Pristiq correctly. The success of our program over the past
14 years is due to our unmatched service and unique mentoring approach. Pristiq is dangerous to abruptly or rapidly stop and our program is a proven, viable, low-cost option to continue living your life while tapering.
Read program FAQ page.
We are prescription drug experts that specialize in Antidepressant withdrawals.
Here I am, at the other side. I've returned to my life but it's better than it was before because I have such gratitude and appreciation for all that I have. more...
- Suzy L., (Canada) Pristiq, Temazepam
Key Components of Our In-Home Program
Skilled Experts in Prescription Drugs guiding you throughout the process.
Professional, kind mentoring
Assessment at the onset to determine taper rates, potential interactions, etc.
- *Nutraceuticals specially formulated to ease symptoms, these are utilized throughout the whole process
Unlike herbs and many vitamins, our nutraceuticals will not interact with any medications
- Information, advice and direction
24/7 discussion board with encouraging members and knowledgeable mentors
- Email and phone access at no charge
Recommendations for addressing symptoms such as gut problems, headaches, pain, etc.
- Experienced team of committed experts with over 14 years experience
Every person at Point of Return has a personal story with these drugs. You are never alone
Call toll-free 866-605-2333 to Learn More or send us an Email.
Break Free Today
At Point of Return, a 501(c)3 nonprofit, we have spent the last 14 years helping people taper off antidepressants correctly. With customized taper rates and all natural nutraceuticals, our program allows you to control
your symptoms and properly come off Pristiq, once and for all, from the comfort of your home.
Read program FAQs
reach out for help
Pristiq history and info
Pristiq (Desvenlafaxine) is the active metabolite of Effexor (Venlafaxine) and was approved in January 2007. While Pristiq was approved in both the United States and Canada, the European Union declined the status, stating in part that Pristiq (marketed under the name Ellefore in Europe) "the Committee for Medicinal Products for Human Use had some concerns and was of the provisional opinion that Ellefore could not have been approved for the treatment of major depressive disorder [and] overall, the effectiveness of Ellefore had not been shown convincingly. In relation to its parent substance, Venlafaxine, Desvenlafaxine seemed to be less effective with no advantages in terms of safety and tolerability." Wyeth subsequently withdrew its application for approval.
In December 2015 Pfizer announced the results from a Phase 3 study evaluating the efficacy, safety and tolerability of Pristiq (sustained release) in pediatric patients ages 7-17 with Major Depressive Disorder. The results indicate that Pristiq were not significantly different from placebo.
*While great care has been taken in organizing and presenting the material throughout this website, please note that it is provided for informational purposes only and should not be taken as Medical Advice.
*Because prescription medications can cause severe withdrawal reactions, do not stop taking any medication without first consulting your physician. The decision to taper any medication should be discussed with your doctor and done with their consent and support. More...